HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nematode asparaginyl-tRNA synthetase resolves intestinal inflammation in mice with T-cell transfer colitis.

Abstract
The therapeutic effects of a controlled parasitic nematode infection on the course of inflammatory bowel disease (IBD) have been demonstrated in both animal and human models. However, the inability of individual well-characterized nematode proteins to recreate these beneficial effects has limited the application of component immunotherapy to human disease. The nematodes that cause chronic human lymphatic filariasis, Brugia malayi and Wuchereria bancrofti, are among the parasites that induce immune suppression. Filarial lymphatic pathology has been shown to involve NF-κB pathway-dependent production of vascular endothelial growth factor (VEGF), and stimulation of VEGF expression has also been reported by interleukin 8 (IL-8) via NF-κB pathways. Previously, we have shown that the filarial asparaginyl-tRNA synthetase (rBmAsnRS) interacts with IL-8 receptors using a combination of extracellular loops that differ from those bound by IL-8. To test the hypothesis that rBmAsnRS might induce an anti-inflammatory effect in vivo, we studied the effects of rBmAsnRS in an established murine colitis model using T-cell transfer mice. T-cell transfer colitis mice treated intraperitoneally with 100 μg of rBmAsnRS four times over 2 weeks showed resolution of cellular infiltration in the colonic mucosa, along with induction of a CD8(+) cellular response. In addition, rBmAsnRS induced a rise in IL-10 production from CD3(+) and lipopolysaccharide (LPS)- and cytosine phosphate guanosine (CPG)-stimulated splenic cells. In summary, this work demonstrates a novel anti-inflammatory nematode protein, supports the hygiene hypothesis, and supports continued refinement of alternative immunotherapies for treatment of IBD.
AuthorsMichael A Kron, Ahmed Metwali, Sanja Vodanovic-Jankovic, David Elliott
JournalClinical and vaccine immunology : CVI (Clin Vaccine Immunol) Vol. 20 Issue 2 Pg. 276-81 (Feb 2013) ISSN: 1556-679X [Electronic] United States
PMID23254300 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • CD3 Complex
  • Homeodomain Proteins
  • Inflammation Mediators
  • Interleukin-8
  • Lipopolysaccharides
  • NF-kappa B
  • RNA, Transfer, Amino Acyl
  • Receptors, Interleukin-8
  • Vascular Endothelial Growth Factors
  • RAG-1 protein
  • Interleukin-10
  • Piroxicam
  • Aspartate-tRNA Ligase
  • asparaginyl-tRNA synthetase
Topics
  • Animals
  • Aspartate-tRNA Ligase (biosynthesis, immunology, metabolism)
  • Brugia malayi (enzymology, immunology)
  • CD3 Complex (biosynthesis)
  • CD8-Positive T-Lymphocytes (immunology)
  • Colitis (chemically induced, immunology, therapy)
  • Dendritic Cells
  • Homeodomain Proteins (genetics)
  • Immunotherapy
  • Inflammation
  • Inflammation Mediators
  • Interleukin-10 (biosynthesis)
  • Interleukin-8 (biosynthesis)
  • Intestinal Mucosa (immunology, pathology)
  • Intestines (immunology, parasitology)
  • Lipopolysaccharides
  • Mice
  • Mice, Inbred C57BL
  • NF-kappa B (metabolism)
  • Piroxicam
  • RNA, Transfer, Amino Acyl (biosynthesis, immunology, metabolism)
  • Receptors, Interleukin-8 (metabolism)
  • Vascular Endothelial Growth Factors (biosynthesis)
  • Wuchereria bancrofti (enzymology, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: